European Researchers Invited to Submit Study Proposals for Bristol-Myers Squibb's Partnering for Cure™ Virology Research Programme

European Researchers Invited to SubmitEuropean Researchers Invited to Submit Study Proposals for Bristol-Myers Squibb's Partnering for Cure™ Virology Research Programme PR Newswire PARIS, April 8, 2014 Partnering for Cure is Bristol-Myers Squibb's flagship, Pan-European scientific initiative supporting breakthrough research and facilitating greater collaboration and knowledge-sharing with the virology community TMIn advance of this year's International Liver Congress 2014 in London, England, Bristol-Myers Squibb invites European researchers to submit innovative research ideas that aim to cure chronic virological diseases. As part of Bristol-Myers Squibb's ongoing commitment in virology, these projects provide an opportunity for researchers, particularly junior faculty and young investigators, to accelerate novel solutions that could lead to cures in HIV, hepatitis B (HBV) and hepatitis C (HCV). This latest round of research applications will be accepted from 1 May to 15 July 2014 and aspiring scientists are encouraged to submit their ideas at http://www.bms.com/israpplications. Priority will be given to research proposals in the area of translational science with a clear relevance for the clinical development of a cure in viral hepatitis or HIV infection. Partnering for Cure is led by the Partnering for CureFaculty, an expert panel of clinical and research experts from across Europe and focuses on three pillars - education, scientific exchange and scientific research.